ARNA trade mark is officially registered

We are excited to announce that our application for registration of ARNA trademark has been approved, which is now officially confirmed by two Certificates for trademarks No. 693554 and No. […]

ARNA Genomics has been approved for Softlanding Program in Germany

We are excited to inform you that ARNA Genomics US Inc. has been qualified for participation in Softlanding Program in Germany. Participation in this program will allow company to gain […]

Подводим итоги 2018 года — обращение СЕО

Уважаемые коллеги и друзья! В преддверии наступающего нового 2019 года нам хотелось бы подвести итоги работы компании и поделиться нашими планами. 2018 год стал для нас особенным годом. В этом […]

Results of 2018 — a word from CEO

Dear colleagues and friends! In anticipation of the upcoming new 2019, we would like to take summarise results of our work in 2018 and share with you some our plans. […]

Professor of Sechenov University presented results of a proof-of-concept study of the test ARNA Breast Cancer

During the XXII Russian Oncological Congress professor of Sechenov Medical University, Head of Personalized Oncology Center “OncoTarget”, Marina Sekacheva, presented the results of a proof-of-concept ARNA Breast Cancer test. Results […]

ARNA took part in the 7th International Forum “Clinical Trials in Russia”

ARNA Genomics CEO Egor Melnikov took part in the discussion “Clinical research of medical devices” at the 7th international forum “Clinical research in Russia”. During the discussion, it was possible […]